Floatation REST: Sensory Reduction for Stress, Pain, and Anxiety

How floating in a dark, silent tank of Epsom salt water reduces sensory input to the nervous system, lowering anxiety, easing chronic pain, and promoting deep relaxation

Float tanks — also called floatation REST (Restricted Environmental Stimulation Therapy) — are pods or rooms filled with water saturated with around 500 kg of Epsom salt, heated precisely to skin temperature, in complete darkness and silence. You float effortlessly on the surface because the density of the water is so high that sinking is essentially impossible. With no light, no sound, no feeling of gravity, and no temperature sensation, the nervous system loses almost all incoming sensory data. Research shows this produces a state of deep relaxation that substantially reduces anxiety, lowers blood pressure and cortisol, and in people with anxiety disorders, provides clinically meaningful relief that can last for more than 48 hours after a single session. [1][5]

How Floatation REST Works

The scientific name — Restricted Environmental Stimulation Therapy — captures the mechanism precisely. The brain is constantly processing sensory input: sound, light, temperature, gravity, proprioception (the sense of where your body is in space). Float tanks reduce all of these to near zero.

With so little incoming data to process, the brain undergoes a distinctive shift. Research measuring heart rate variability, breathing rate, and blood pressure during floats shows a significant transition toward parasympathetic dominance — the rest-and-digest state that is the opposite of the stress response. [5] Specifically:

Systolic and diastolic blood pressure drop measurably during the session
Breathing rate slows
High-frequency heart rate variability (a marker of vagal tone and relaxation) increases
Circulating norepinephrine (a stress hormone) decreases after sessions

This is the autonomic nervous system calming itself when the barrage of sensory information is removed. For people whose nervous systems are chronically over-activated by anxiety, stress, or chronic pain, the effect can feel profound.

The Epsom salt (magnesium sulfate) also plays a role beyond buoyancy. The skin absorbs some magnesium during a float, and magnesium is involved in over 300 enzymatic reactions including muscle relaxation and nervous system regulation — though the magnitude of transdermal absorption relative to the relaxation effect is not yet well quantified.

Anxiety and Depression

The strongest evidence for floatation REST is in anxiety. A landmark 2018 study recruited 50 participants with anxiety disorders including PTSD, generalized anxiety, panic disorder, agoraphobia, and social anxiety — most with comorbid depression. A single float session produced an estimated reduction in state anxiety with a Cohen's d effect size greater than 2, which is exceptionally large for a brief intervention. Participants also reported significant reductions in stress, muscle tension, pain, and depression, alongside improvements in serenity, relaxation, and overall wellbeing. These effects were consistent across all anxiety diagnoses. [1]

A 2024 randomized controlled trial followed this with 75 anxious and depressed participants assigned to six sessions of floatation-REST across different formats (weekly sessions vs. flexible scheduling vs. chair-REST as an active comparator). All floatation formats were well-tolerated with minimal negative effects. Multiple sessions were feasible and continued to produce the positively-valenced experiences seen in single-session studies. [2]

It is worth noting that floatation REST does not require any particular mental technique or prior experience — participants simply lie in the water. This distinguishes it from meditation, which also modulates the stress response but demands sustained practice and effort.

Chronic Pain

A 2021 randomized clinical trial in JAMA Network Open tested floatation-REST in 99 patients with chronic pain, comparing five REST sessions against an indistinguishable placebo and a wait-list control. In the short term, float sessions produced significant increases in relaxation and significant decreases in anxiety, pain intensity, the number of body areas in pain, and pain widespreadness. These short-term benefits were consistent across participants. However, the study found no statistically significant long-term benefits one week after the final session, and the short-term improvements could not be attributed specifically to sensory restriction (since the placebo arm was also partially effective). [3]

The pain findings suggest floatation REST is useful for symptom relief in the moment — a real and meaningful benefit for people with chronic pain who need periodic relief — but it is not yet established as a disease-modifying treatment.

What a 2025 Systematic Review Found

A comprehensive systematic review published in BMC Complementary Medicine and Therapies analyzed the flotation-REST literature from the earliest papers in 1960 through May 2024, covering 63 studies. The review found generally positive effects on pain, athletic performance, stress, mental wellbeing, and clinical anxiety. The evidence was stronger in clinical populations (people with anxiety disorders or chronic pain) than in healthy populations, and the research base has improved considerably in quality over recent decades. [4]

What to Expect

A typical float session lasts 60–90 minutes. First-timers often spend the first 20–30 minutes adjusting — noticing their thoughts, relaxing the urge to move, or managing mild claustrophobia. Most people report that by the second half of the session, they reach a genuinely unusual state of mental quiet. Some fall asleep.

Float centers offer pods (enclosed capsules) or open rooms — both achieve the same sensory environment. The water temperature is maintained at approximately 34.5°C (94°F), which matches skin surface temperature so closely that the boundary between body and water becomes difficult to perceive.

Epsom salt solutions are heavily concentrated — roughly 10 times saltier than seawater — and are continuously filtered and sanitized between uses.

A preventive health pilot trial found that regular flotation sessions (once a week for 12 weeks) significantly reduced perceived stress, depression, and anxiety in healthy adults compared to a waiting list control, suggesting benefit even before clinical thresholds are reached. [6]

See our cold exposure page and sauna page for related practices that work through different but complementary mechanisms.

Evidence Review

Anxiety: The Feinstein 2018 Benchmark Study

Feinstein et al. (PMID 29394251) remains the most cited single-session floatation study. The sample of 50 participants spanned PTSD (n=9), generalized anxiety (n=16), panic disorder and/or agoraphobia (n=9), social anxiety (n=11), and specific phobia (n=5), with 46 of 50 participants also meeting criteria for unipolar depression. Participants completed validated questionnaires before and immediately after a single 90-minute float session (using the Spielberger State-Trait Anxiety Inventory, the Profile of Mood States, the Depression Anxiety Stress Scale, and a custom Float Experience Questionnaire).

Across all diagnosis categories without exception, state anxiety dropped substantially post-float, with a pooled estimated effect size (Cohen's d) exceeding 2. To calibrate that magnitude: most pharmacological and psychotherapy anxiety interventions produce effect sizes of 0.5–1.2. Measures of depression, stress, muscle tension, pain, and negative affect also showed significant improvements. Positive affect measures — serenity, relaxation, happiness — all increased significantly (p < .0001). The findings were remarkably consistent across all five anxiety subtypes, which the authors interpreted as suggesting floatation REST targets a common neurobiological substrate underlying anxiety rather than disorder-specific mechanisms.

Limitations: no control group, no randomization in the 2018 study, and the absence of a follow-up measurement means the duration of effect is not quantified (though a subsequent study found effects persisted beyond 48 hours). The effect sizes, while striking, require replication with appropriate controls.

Randomized Controlled Feasibility Trial: Flux et al. 2024

Flux et al. (PMID 38843272) addressed key methodological gaps with a 75-participant RCT comparing pool-REST (weekly 1-hour sessions), pool-REST preferred (flexible duration and timing), and an active comparator (chair-REST, weekly 1-hour sessions in a zero-gravity recliner). Participants had anxiety and/or depression.

Six sessions of floatation-REST were safe and well-tolerated. Adverse events were rare and minor. Floatation consistently produced positively-valenced subjective experiences — rated for calmness, positive emotions, and insight — that chair-REST did not match to the same degree. This RCT design provides the first randomized evidence that the floatation environment itself, not merely the structured rest time, contributes to the observed effects. The trial was powered for feasibility rather than efficacy, so definitive effect size estimates await a fully powered Phase III trial.

Chronic Pain: JAMA Network Open 2021

Loose et al. (PMID 33988708) conducted the most methodologically rigorous pain trial to date. Their study enrolled 99 chronic pain patients and used a genuinely novel design: the active intervention was floatation-REST, the placebo was a physically indistinguishable control condition (lying supine in shallow water without sensory reduction), and the third arm was a wait-list control. Single-blinding of raters was maintained.

After five sessions over approximately five weeks, floatation-REST produced statistically significant short-term improvements (measured immediately post-session and 24 hours later) in pain intensity, number of painful body areas, pain widespreadness, relaxation, and anxiety. However, follow-up measurement one week after the final session showed no significant group differences — the gains did not persist. The placebo arm also showed some improvement, suggesting that expectation and the sensory novelty of the protocol contribute to short-term relief independently of environmental stimulation restriction.

This is an important result: it establishes that floatation-REST produces real, if transient, pain relief, but tempers claims about it as a lasting treatment. Longer treatment courses, maintenance schedules, or combination with other treatments may be needed to produce sustained analgesia.

Cardiovascular Mechanisms: Flux et al. 2022

Flux et al. published real-time cardiovascular monitoring during floatation-REST using wireless, waterproof equipment — measuring heart rate, HRV, breathing rate, and blood pressure throughout the session. Compared to a film-watching control condition, floating produced measurable reductions in both systolic and diastolic blood pressure, slowing of breathing rate, and increases in high-frequency HRV — an index of vagal (parasympathetic) nervous system tone. Frequency-domain HRV analysis indicated a shift toward higher vagal modulation through reduced sympathetic baroreflex output. Circulating norepinephrine decreased post-float in prior studies. [5]

Together, these findings support the hypothesis that the anxiolytic and pain-relieving effects of floatation REST operate substantially through autonomic nervous system recalibration — specifically, a shift from sympathetic (stress-response) dominance toward parasympathetic (rest-and-recover) dominance that can be achieved reliably and reproducibly by reducing sensory input.

Preventive Health: Kjellgren and Westman 2014

This randomized controlled pilot trial (PMID 25344737) assigned 65 healthy adults to either 12 weeks of once-weekly floatation sessions or a waiting-list control. At the 12-week assessment, the floatation group showed significantly lower perceived stress, anxiety, and depression, and higher sleep quality and optimism. The effects were present in people who did not have clinical diagnoses, suggesting the practice is useful as a wellness intervention in the general population, not only in those with disorder-level symptoms.

Overall Evidence Assessment

Floatation REST has an unusually consistent evidence base for a wellness modality: the direction of effect on anxiety is robust across multiple studies, designs, and populations, with extraordinarily large effect sizes in the anxiety literature. The cardiovascular mechanism is directly measured rather than inferred. The main limitations are: most studies are small, the absence of a standardized protocol (session length, number of sessions, and scheduling vary across studies), and the need for adequately powered Phase III trials before floatation REST can be recommended as a primary clinical treatment for anxiety disorders. For general wellness, stress management, and adjunctive pain relief, the evidence is sufficiently consistent to support use.

References

Examining the short-term anxiolytic and antidepressant effect of Floatation-RESTFeinstein JS, Khalsa SS, Yeh HW, Wohlrab C, Simmons WK, Stein MB, Paulus MP. PLoS One, 2018. PubMed 29394251 →
A randomized controlled safety and feasibility trial of floatation-REST in anxious and depressed individualsFlux MC, Fine TH, Poplin T, Van Voorhees E, Blaess MK, Martin SL, Yeh HW, Khalsa SS, Feinstein JS. PLoS One, 2024. PubMed 38843272 →
Flotation Restricted Environmental Stimulation Therapy for Chronic Pain: A Randomized Clinical TrialLoose LF, Manuel J, Karst M, Schmidt LK, Beissner F. JAMA Network Open, 2021. PubMed 33988708 →
A systematic review of flotation-restricted environmental stimulation therapy (REST)van der Linden D, van der Linden J, Weegenaar L, Boersma GJ. BMC Complementary Medicine and Therapies, 2025. PubMed 40611079 →
Exploring the acute cardiovascular effects of Floatation-RESTFlux MC, Fine TH, Yeh HW, Khalsa SS, Feinstein JS. Frontiers in Neuroscience, 2022. Source →
Beneficial effects of treatment with sensory isolation in flotation-tank as a preventive health-care intervention — a randomized controlled pilot trialKjellgren A, Westman J. BMC Complementary and Alternative Medicine, 2014. PubMed 25344737 →